{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-028954","form_type":"8-K","ticker":"DFTX","cik":"0001813814","company_name":"Definium Therapeutics, Inc.","filed_at":"2023-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.778680+00:00","generated_at":"2026-06-13T21:37:12.009901+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"MindMed holds Analyst Day focused on MM-120 for GAD; no specific data disclosed","bullets":["Analyst Day held June 20, 2023 in New York, NY.","Presentation centered on MM-120 program for generalized anxiety disorder (GAD).","Exhibit 99.1 filed but contains only cover page; substantive slides not included.","No clinical results, financial guidance, or milestones announced in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-028954","json":"https://secwatch.observer/filing/0000950170-23-028954.json","markdown":"https://secwatch.observer/filing/0000950170-23-028954.md","text":"https://secwatch.observer/filing/0000950170-23-028954.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023028954/0000950170-23-028954-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023028954/mnmd-20230620.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T21:37:12.009901+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}